Spinal Cord Stimulation in Low Back and Leg Pain

Abstract

We have reviewed our experience with spinal cord stimulation (SCS) in patients with low back and leg pain. 33 patients complaining of leg and low back pain underwent percutaneous tests of SCS. 28 patients had failed back surgery syndromes, 1 patient had pain related to an L1 vertebral body fracture, another from Tarlow cysts and the remaining 3 patients had lumbosacral spondyloarthrosis and osteoporosis without radiological signs of root compression. 28 patients showed mono- or pluriradicular deficits. At the end of the test period (5–65 days), 21 patients (63.6%) reported more than 50% of pain relief (mean analgesia 75%) and were submitted to chronic stimulation. The mean follow-up was 45.5 months. At maximum available follow-up, 40% of the patients (13 out of the 33 initial patients) were successfully using the stimulator (mean analgesia 66.6%).

Long-Term Outcomes of Spinal Cord Stimulation With Paddle Leads in the Treatment of Complex Regional Pain Syndrome and Failed Back Surgery Syndrome

“…Spinal cord stimulation (SCS) is a safe, reversible, and efficacious treatment option for select patients with medically intractable chronic pain syndromes such as failed back surgery syndrome (FBSS) and complex regional pain syndrome (CRPS) (1–13). SCS systems are routinely implanted after a trial with percutaneous leads.…”

Spinal cord stimulation in the treatment of neuropathic pain: Current perspectives of indications, cost-effectiveness, complications and results

“…Patients diagnosed with CRPS, FBSS (Figures 4 and 5), and PHN have shown significant success rates in pain management and cost-effectiveness associated with low rates of complications. The total pain management was rarely obtained by the use of SCS as therapy as indicated in Tables 2-4 (22,38,39,41,50,58,60,(65)(66)(67).…”

Spinal cord stimulation in the treatment of failed back surgery syndrome

“…Meglio et al [5] reported on their experience with 33 patients with leg and back pain. Most of these patients (28) had FBSS, and all were evaluated with a trial of percutaneous electrode stimulation.…”